|
|
Current Issue:
January-March 2021 | Vol 58 | Issue 1 |
|
| LETTER FROM THE EDITOR |
|
| Outgoing editor's thoughts – On Sisyphean tasks and the last refuge of scoundrels |
|
|
|
| Sanjay A Pai |
|
|
This issue of the Indian Journal of Cancer (January-March 2021) marks the changing of the guard. I have, of course, been responsible for putting together much of the contents of this issue as it was... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| |
| Editorial |
|
| Epidermal growth factor receptor mutated lung cancers: Looking beyond adenocarcinomas |
|
|
|
| Saurabh Zanwar |
|
|
The discovery of mutations in the epidermal growth factor receptor (EGFR) mutations in metastatic non-small cell lung cancer (NSCLC) has been a focal point in changing the treatment landscape of the... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
Read more.... |
|
|
 |
|
Indian Journal of Cancer (ISSN 0019-509X), the show window of the
progress of oncological sciences in India, was established in 1963.
Indian Journal of Cancer is the first and only periodical serving the
needs of all the specialties of oncology in India. Its international
repute is recognized by its indexing with most bibliographic databases
including MEDLINE, Index Medicus, EMBASE and Biological Abstracts.
The readership has expanded beyond the boundaries of thecountry.
Apart from journal's |
own website, the internet issue of the journal has
been made available with collaboration with Bioline International,
Canada. The journal's content from www.bioline.org.br/cn attracts more
than 5000 visitors per month, from all over the world. The journal
utilizes most advanced tools for its management including an electronic
system for manuscript submission and review.
More >>
|
|
